Join
Live feed
·
PRReleasevia Quantisnow
Amylyx Pharmaceuticals Inc. logo

Amylyx Pharmaceuticals Announces Publication of Survival Analysis Comparing CENTAUR to Historical Clinical Trial Control

ByQuantisnow·Wall Street's wire, on your screen.
AMLX· Amylyx Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AMLX (Amylyx Pharmaceuticals Inc.) and more on Quantisnow.